This federal contract award, valued at $8,731.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the delivery of 200-unit vials of BOTOX, a pharmaceutical product, with a completion date of August 21, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award, valued at $5,128.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200-unit vials of the drug BOTOX, with a completion date of January 29, 2025. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $58,213, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOTOX 200 unit vials and has a period of performance through September 2024.
The award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $7,227.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is a Delivery Order (DO) for the supply of 4,566,760,832 units of Botox 200 unit vials, with a firm fixed price pricing type and a completion date of January 9, 2025.
The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a $5,821.30 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 200-unit vials of Botox. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which enables the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award, valued at $17,095.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200-unit vials of Botox, a pharmaceutical product.
The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This larger...
This federal contract award is for the delivery of 4,564,821,337 vials of BOTOX 200 unit vials to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract, valued at $23,285.20, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 5, 2024 with a completion date of June 27, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen Drug Corp holds a larger...
The federal contract award is for the delivery of 200 unit vials of BOTOX to the Defense Logistics Agency (DLA) Troop Support Medical, a major customer of the prime contractor Amerisourcebergen Drug Corp. The firm-fixed-price contract has a ceiling value of $8,731.95 and a completion date of August 8, 2024. This contract is a delivery order placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through...
The federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,296.60 firm fixed-price delivery order is for the procurement of 100-unit vials of BOTOX medication, with a completion date of December 23, 2024.
This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $90,337.50 delivery order contract is for the supply of BOTOX 200 unit vials, with a period of performance through December 17, 2024.
The contract is a firm fixed-price arrangement and is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...